Literature DB >> 12122106

Making room for T cells.

Gabriel N Maine1, James J Mulé.   

Abstract

Mesh：

Substances：

Year:  2002        PMID： 12122106      PMCID： PMC151072          DOI： 10.1172/JCI16166

Source DB:  PubMed          Journal:  J Clin Invest        ISSN： 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  22 in total

1.  Naïve cytotoxic T lymphocytes spontaneously acquire effector function in lymphocytopenic recipients: A pitfall for T cell memory studies?

Authors:  S Oehen; K Brduscha-Riem
Journal:  Eur J Immunol       Date:  1999-02       Impact factor: 5.532

2.  Tumor lysate-pulsed dendritic cells can elicit an effective antitumor immune response during early lymphoid recovery.

Authors:  W Asavaroengchai; Y Kotera; J J Mulé
Journal:  Proc Natl Acad Sci U S A       Date:  2002-01-15       Impact factor: 11.205

3.  Different contributions of thymopoiesis and homeostasis-driven proliferation to the reconstitution of naive and memory T cell compartments.

Authors:  Qing Ge; Hui Hu; Herman N Eisen; Jianzhu Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2002-03-05       Impact factor: 11.205

4.  Homeostatic T cell proliferation in a T cell-dendritic cell coculture system.

Authors:  Qing Ge; Deborah Palliser; Herman N Eisen; Jianzhu Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2002-02-19       Impact factor: 11.205

5.  Dendritic cells pulsed with fungal RNA induce protective immunity to Candida albicans in hematopoietic transplantation.

Authors:  Angela Bacci; Claudia Montagnoli; Katia Perruccio; Silvia Bozza; Roberta Gaziano; Lucia Pitzurra; Andrea Velardi; Cristiana Fe' d'Ostiani; Jim E Cutler; Luigina Romani
Journal:  J Immunol       Date:  2002-03-15       Impact factor: 5.422

6.  IL-7 enhances the survival and maintains the size of naive T cells.

Authors:  J C Rathmell; E A Farkash; W Gao; C B Thompson
Journal:  J Immunol       Date:  2001-12-15       Impact factor: 5.422

7.  Cutting edge: Regulatory T cells from lung cancer patients directly inhibit autologous T cell proliferation.

Authors:  Edward Y Woo; Heidi Yeh; Christina S Chu; Katia Schlienger; Richard G Carroll; James L Riley; Larry R Kaiser; Carl H June
Journal:  J Immunol       Date:  2002-05-01       Impact factor: 5.422

8.  Synergism of cytotoxic T lymphocyte-associated antigen 4 blockade and depletion of CD25(+) regulatory T cells in antitumor therapy reveals alternative pathways for suppression of autoreactive cytotoxic T lymphocyte responses.

Authors:  R P Sutmuller; L M van Duivenvoorde; A van Elsas; T N Schumacher; M E Wildenberg; J P Allison; R E Toes; R Offringa; C J Melief
Journal:  J Exp Med       Date:  2001-09-17       Impact factor: 14.307

9.  Naive T cells transiently acquire a memory-like phenotype during homeostasis-driven proliferation.

Authors:  A W Goldrath; L Y Bogatzki; M J Bevan
Journal:  J Exp Med       Date:  2000-08-21       Impact factor: 14.307

10.  Homeostasis-stimulated proliferation drives naive T cells to differentiate directly into memory T cells.

Authors:  B K Cho; V P Rao; Q Ge; H N Eisen; J Chen
Journal:  J Exp Med       Date:  2000-08-21       Impact factor: 14.307
View more
  19 in total

Review 1.  Exploitation of the propulsive force of chemotherapy for improving the response to cancer immunotherapy.

Authors:  Enrico Proietti; Federica Moschella; Imerio Capone; Filippo Belardelli
Journal:  Mol Oncol       Date:  2011-12-03       Impact factor: 6.603

2.  Hematopoietic stem cells promote the expansion and function of adoptively transferred antitumor CD8 T cells.

Authors:  Claudia Wrzesinski; Chrystal M Paulos; Luca Gattinoni; Douglas C Palmer; Andrew Kaiser; Zhiya Yu; Steven A Rosenberg; Nicholas P Restifo
Journal:  J Clin Invest       Date:  2007-02       Impact factor: 14.808

3.  Enhancement of antitumor immunity by low-dose total body irradiationis associated with selectively decreasing the proportion and number of T regulatory cells.

Authors:  Rongjun Liu; Shudao Xiong; Lei Zhang; Yiwei Chu
Journal:  Cell Mol Immunol       Date:  2010-02-08       Impact factor: 11.530

Review 4.  Tumor immunity via homeostatic T cell proliferation: mechanistic aspects and clinical perspectives.

Authors:  Roberto Baccala; Rosana Gonzalez-Quintial; Wolfgang Dummer; Argyrios N Theofilopoulos
Journal:  Springer Semin Immunopathol       Date:  2005-01-22

5.  Activating systemic T-cell immunity against self tumor antigens to support oncolytic virotherapy with vesicular stomatitis virus.

Authors:  Phonphimon Wongthida; Rosa Maria Diaz; Christine Pulido; Diana Rommelfanger; Feorillo Galivo; Karen Kaluza; Timothy Kottke; Jill Thompson; Alan Melcher; Richard Vile
Journal:  Hum Gene Ther       Date:  2011-04-11       Impact factor: 5.695

6.  Interleukin-7-dependent expansion and persistence of melanoma-specific T cells in lymphodepleted mice lead to tumor regression and editing.

Authors:  Li-Xin Wang; Rui Li; Guojun Yang; May Lim; Aisling O'Hara; Yiwei Chu; Bernard A Fox; Nicholas P Restifo; Walter J Urba; Hong-Ming Hu
Journal:  Cancer Res       Date:  2005-11-15       Impact factor: 12.701

7.  Lymphodepletion followed by donor lymphocyte infusion (DLI) causes significantly more acute graft-versus-host disease than DLI alone.

Authors:  Jeffrey S Miller; Daniel J Weisdorf; Linda J Burns; Arne Slungaard; John E Wagner; Michael R Verneris; Sarah Cooley; Rosanna Wangen; Susan K Fautsch; Roby Nicklow; Todd Defor; Bruce R Blazar
Journal:  Blood       Date:  2007-06-19       Impact factor: 22.113

Review 8.  Hyperthermia as an immunotherapy strategy for cancer.

Authors:  Joseph J Skitzki; Elizabeth A Repasky; Sharon S Evans
Journal:  Curr Opin Investig Drugs       Date:  2009-06

9.  Tumour cell contamination of autologous stem cells grafts in high-risk neuroblastoma: the good news?

Authors:  R Handgretinger; W Leung; K Ihm; P Lang; T Klingebiel; D Niethammer
Journal:  Br J Cancer       Date:  2003-06-16       Impact factor: 7.640

10.  In vivo cyclophosphamide and IL-2 treatment impedes self-antigen-induced effector CD4 cell tolerization: implications for adoptive immunotherapy.

Authors:  Marianne A Mihalyo; Amy D H Doody; Jeremy P McAleer; Elizabeth C Nowak; Meixiao Long; Yi Yang; Adam J Adler
Journal:  J Immunol       Date:  2004-05-01       Impact factor: 5.422
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.